Variable reproducibility in genome-scale public data: A case study using ENCODE ChIP sequencing resource  by Devailly, Guillaume et al.
FEBS Letters 589 (2015) 3866–3870journal homepage: www.FEBSLetters .orgVariable reproducibility in genome-scale public data: A case study using
ENCODE ChIP sequencing resourcehttp://dx.doi.org/10.1016/j.febslet.2015.11.027
0014-5793/ 2015 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Abbreviations: ENCODE, encyclopaedia of DNA elements; TFBS, transcription
factor binding site; ChIP, chromatin immunoprecipitation; ChIP-seq, ChIP followed
by massively parallel sequencing; UV, ultraviolet; FAANG, functional annotation of
animal genomes; UCSC, University of California, Santa Cruz; TSS, transcriptional
start site; FRiP, Fraction of Reads in Peaks; FPKM, Fragments per Kilo base per
Million
Author contributions: G.D. collected the data and performed the analysis with the
help of A.M., A.J. conceived the idea and G.D, A.J. and T.M. wrote the manuscript.
⇑ Corresponding author.Guillaume Devailly, Anna Mantsoki, Tom Michoel, Anagha Joshi ⇑
The Roslin Institute, University of Edinburgh, Easter Bush Campus, Midlothian EH25 9RG, United Kingdom
a r t i c l e i n f oArticle history:
Received 7 July 2015
Revised 2 November 2015
Accepted 16 November 2015
Available online 24 November 2015
Edited by Paul Bertone
Keywords:
Encyclopaedia of DNA element
Chromatin immunoprecipitation
sequencing
Transcription factor
Data integrationa b s t r a c t
Genome-wide data is accumulating in an unprecedented way in the public domain. Re-mining this
data shows great potential to generate novel hypotheses. However this approach is dependent on
the quality (technical and biological) of the underlying data. Here we performed a systematic anal-
ysis of chromatin immunoprecipitation (ChIP) sequencing data of transcription and epigenetic fac-
tors from the encyclopaedia of DNA elements (ENCODE) resource to demonstrate that about one
third of conditions with replicates show low concordance between replicate peak lists. This serves
as a case study to demonstrate a caveat concerning genome-wide analyses and highlights a need
to validate the quality of each sample before performing further associative analyses.
 2015 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical
Societies. This is an open access article under the CC BY license (http://creativecommons.org/licenses/
by/4.0/).1. Introduction
The ENCODE project has set up a model to generate large data to
understand mammalian transcription control by pooling resources
across the globe. The easy accessibility of these data, including pro-
cessed files, has resulted into many researchers world-wide using
the ENCODE resource to learn new biology, either by integrating
existing data [1] or by integrating with their own new data [2].
An especially valuable part of the ENCODE resource concerns the
identification of the binding sites of transcription factors and
chromatin modifiers at genome-wide scale using chromatin
immuno-precipitation (ChIP) followed by high throughput
sequencing (ChIP-seq). This relies on a complex experimental
setup involving antibodies, a fragmentation step, chemical or UV
cross-link and library preparation from very small amount of
DNA [3]. Using these data, regulators have been assigned various
roles that are sometimes contradictory [4]. This suggests thatdespite the high technical quality control of individual samples
by the ENCODE consortium [5], serving as a model for many other
consortia (BLUEPRINT Epigenetics, Roadmap Epigenomics, FAANG),
the post-processing of samples to determine their biological
relevance is still incomplete. To investigate this issue, we per-
formed a systematic analysis of the conditions of ChIP sequencing
data with replicate experiments in the ENCODE resource.
The ENCODE consortium at UCSC provides 690 ChIP sequencing
data sets for transcription factors and transcription regulators, per-
formed using 189 different antibodies in 91 cell lines, sometimes
under different cell treatments. It contains 57 conditions where
ChIP-seq for the same factor in the same cell line with the same
treatment (or absence of treatment) were done multiple times
(between 2 and 5, for a total of 135 experiments and corresponding
peak lists) and not merged. These experiments were not merged
because they differ in one or more of the following: antibody used
for the ChIP, laboratory that performed the experiment, or library
preparation protocol for the sequencing. It is not mentioned
whether these replicates give redundant information, complemen-
tary information, or if one of the replicates is of higher quality than
the other(s), leaving the end user unarmed to decide which peak
list should be used. Notably, these peak lists have also not been
merged in other ENCODE data repositories such as encodeproject.
org or factorbook.org [6]. Therefore, for each of the 57 conditions
with unmerged replicates, we compared individual experiment
quality using various approaches and identified 18 conditions
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experiment(s). In these cases, downstream analyses of one peak
list or another can lead to different results.
2. Materials and methods
ChIP-seq experiments with replicates in the ENCODE TFBS
dataset were identified and uniform TFBS peaks files for the
corresponding samples were downloaded from the website
http://hgdownload.cse.ucsc.edu/goldenPath/hg19/encodeDCC/
wgEncodeAwgTfbsUniform/ (Uniform SPP peaks). Common and
sample specific peaks were identified using bedtools [7], with a
minimal overlap of one base pair. Additionally, for 6 conditions
with 2 replicates, alternative peakSeq peak lists were downloaded
from http://ftp.ebi.ac.uk/pub/databases/ensembl/encode/integration_
data_jan2011/byDataType/peaks/jan2011/peakSeq/optimal/hub/.
Bam files for the corresponding experiments were downloaded
from https://www.encodeproject.org/, and merged using Samtools
[8]. The mean coverages around peaks were computed using
Repitools [9]. Statistically significant differentially bound regions
were identified using MAnorm [10] with a 150 base pair read shift.
Peaks were annotated with the closest TSS using bedtools and
GENCODE v21 transcripts annotations [11], after converting the
annotation table into hg19 coordinates using liftOver (99.83%
conversion success). De novo motif analysis was performed using
HOMER [12] function findMotifsGenome.pl. Cluster analysis of all
ENCODE ChIP-seq was done by transformation of the ENCODE
Regulation ‘Txn Factor’ track into a binary matrix (genomic
regions  experiments). The analysis including calculation of
Pearson correlations between experiments and hierarchical clus-
tering was performed using R functions cor() and hclust(). R scripts
used for the entire analysis are available at (https://github.com/
gdevailly/ENCODE-TFBS-replicate-quality).
3. Results
3.1. A third of ENCODE conditions with replicates are of low
concordance, while about a fourth has sensitivity issues
We identified 57 conditions within the ENCODE transcription
and epigenetic factors ChIP sequencing data where the same
experiment was done multiple times (between 2 and 5) for the
same factor in the same cell line with the same treatment (or
absence of treatment), and the replicates were provided without
being merged. For example, the USF1 ChIP-seq in A549 cells
treated with 0.02% of ethanol was performed two times by the
HudsonAlpha laboratory with the same antibody but with two
different library preparation protocols (the ‘‘PCR1x” and the
‘‘V0422111” protocols). Two corresponding peak lists are provided
by the ENCODE (‘‘wgEncodeAwgTfbsHaibA549Usf1V0422111Etoh02U
niPk.narrowPeak” and ‘‘wgEncodeAwgTfbsHaibA549Usf1Pcr1xEto
h02UniPk.narrowPeak”) and both experiments are in different lanes
in the UCSC track (respective experiment ID numbers 68 and 69,
http://hgdownload.cse.ucsc.edu/goldenPath/hg19/encodeDCC/
wgEncodeRegTfbsClustered/wgEncodeRegTfbsClustered.bed.gz).
We first compared the peak overlap between replicate experi-
ments to identify a set of common peaks, detected in every repli-
cate. Using the fraction of common peaks in each experiment as
a measure of replicate consistency, we classified the 57 conditions
in three categories (similar, sensitive and dissimilar). If the overlap
between all replicate peak lists and the common peak list was 50%
or more (i.e. if at least 50% of the peaks were reproducible in every
replicate), then the condition was labelled as ‘‘similar” (Fig. 1A).
Within the non-similar conditions, a special case was made for
conditions where one peak list was at least two times bigger than
another and more than 70% of the smaller peaks list overlappedwith the common peak list. This was labelled as having differences
of sensitivity between replicates, and the condition was classified
as ‘‘sensitive” (Fig. 1B) where the differences across replicates
might reflect differences in ChIP efficiency, with one experiment
with a lower false positive rate, while the other a lower false neg-
ative rate. The remaining conditions were labelled as ‘‘dissimilar”
(Fig. 1C). Of the 57 conditions with replicates, 26 were classified
as ‘‘similar”, 13 were ‘‘sensitive” and 18 were ‘‘dissimilar”
(Table S1). Five of the 18 ‘‘dissimilar” conditions used different
antibodies suggesting the differences might reflect undocumented
isoform specificity of these antibodies. The complete analysis
of overlapping peak lists for each condition is available as
Figs. S4–60, and is summarized in Table S1.
In order to check whether the discrepancies between peak lists
from different replicate experiments might be due to a bias in the
peak detection (or peak calling) procedure instead of representing
true ChIP enrichment differences, we obtained the raw read counts
for each sample from the ENCODE resource. For each of the 135
experiments (from 57 conditions), we computed mean coverage
at ‘‘common peaks” (detected in all replicate experiments targeting
a given TF in a given cell line under a given treatment), at peaks
detected in a given experiment but not in any other replicate
(‘‘sample specific peaks”), and at peaks detected in any of the other
replicates, but missed in a given experiment (‘‘undetected peaks”,
Fig. 1, coverage plots). For the majority of 135 experiments,
the mean coverage at common and sample specific peaks was
higher than at undetected peaks, demonstrating that differences
in peaks indeed largely reflect differences in ChIP enrichment
signals. In a handful of exceptional cases, mean coverage at
undetected peaks was very close to mean coverage at sample
specific peaks (experiment 1 for Rad21 ChIP-seq in HepG2,
Fig. S53C), or peaks were called in one experiment despite a low
read enrichment (experiment 1 for NRSF ChIP-seq in HepG2,
Fig. S36C). These exceptions might be due to potential artefacts
in peak detection. Mean coverage at common peaks was almost
always higher than at sample specific peaks, confirming that
intersecting peak lists indeed selects peaks of higher signal to
noise ratio. Notable exceptions to this are replicate 2 for CHD1
ChIP-seq in H1-hESC (Fig. S9C), c-Myc ChIP-seq in H1-hESC
(Fig. S10C), Pol2 ChIP-seq in K562 (Fig. S50C) and ATF3 ChIP-seq
in K562 (Fig. S5C).
Peak lists generated by another peak caller (peakSeq) for 6
replicates (2 similar, 2 sensitive and 2 dissimilar) classified the
samples in the same groups (Fig. S1. This emphasizes that differ-
ences observed between replicate experiments reflect differences
in raw data and they were not introduced by biased peak detection.
3.2. ChIP-seq signal-to-noise ratio, but not sequencing depth, is always
positively correlated with peak list size
The ‘‘sensitive” conditions mainly represent conflicts due to a
large variation between the numbers of peaks detected across
replicates. We therefore systematically investigated criteria
responsible for the variability in number of detected peaks. One
of the main factors influencing the number of detected peaks is
sequencing depth [13]. For each experiment, we thus compared
the number of peaks and the number of uniquely aligned reads.
Though the number of detected peaks and number of reads fre-
quently showed a positive correlation in general (e.g. Pol2 ChIP-
seq in GM12878, Figs. S43D and E), this was not the case for 3
out of 13 (23%) conditions (Fig. S2A): BHLHE40 ChIP-seq in HepG2
(Fig. 1B, number of peaks and millions of reads plots), CEBP ChIP-
seq in HepG2 (Figs. S7D and E) and COREST ChIP-seq in K562
(Figs. S13D and E). We also explored if differences in signal over
noise ratio (i.e. the level of enrichment obtained after the ChIP)
of these ChIP-seq could explain the differences in the number of
Fig. 1. Assessing variability across TF ChIP-seq replicate experiments. A, B and C: Examples of the classification based on peak overlap. For each panel, numbers on the y-axis
represent experiment ID (full names available in Figs. S5–61A). Number on the x-axis indicates number of peaks. Black: detected peaks. Grey: no peaks were called in that
region. Coverages plot:Mean coverage at detected and undetected peaks. Black lines: mean coverage at common peaks. Dash line: mean coverage at detected peaks that were
not in common with other experiments. Grey line: mean coverage at undetected peaks that were called only in other experiments. FPKM: Fragments per kilo base per
millions. Number of peaks barplot: Number of peaks called in each experiment of BHLHE40 ChIP-seq in untreated HepG2. Black: peaks called in every experiment. Grey: peaks
not called in every experiment. Number of reads barplot:Millions of uniquely aligned reads for each experiment of BHLHE40 ChIP-seq in untreated HepG2. Common peak height
boxplot: Boxplot of FPKM at common peaks for every experiment of BHLHE40 ChIP-seq in untreated HepG2. Peak distribution plot: Distance from the closest TSS was compute
for every peak from both experiments of HDAC2 ChIP-seq in untreated K562. Common peaks were frequently overlapping a TSS. Peaks from experiment number 1 were
generally closer to a TSS than peaks from experiment number 2.Motif logos:Motif logo of the top de novomotif discovery results from peak list of experiment number 1 (left)
and experiment number 2 (right).
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by the ENCODE consortium [5] is sensitive to the number of
detected peaks. We therefore computed peak FPKM (Fragments
per Kilo base per Million) for each experiment at common peaksdetected in every replicate experiments (Fig. 1C, common peak
height plot, Figs. S5–61F). For the 13 ‘‘sensitive” conditions, the
relationship between the total number of peaks detected in an
experiment and the median peak FPKM at common peaks was
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level of ChIP enrichment (i.e. the signal over noise ratio) is a better
predictor of number of detected peaks than the sequencing depth
in a ChIP-seq experiments. Lower ChIP enrichment therefore can-
not practically be compensated for by increasing sequencing depth
in order to detect more peaks. This also highlights the importance
of normalizing data according to their signal over noise ratio, using
appropriate tools, such as MAnorm [10] and DiffBind [14], when
comparing two peak lists from ChIP-seq of the same factor in dif-
ferent cell types or conditions. We applied MAnorm to find statis-
tically different bound regions between replicate experiments for 6
conditions with replicates (Fig. S1). In three (JUND ChIP-seq in
HepG2, YY1 ChIP-seq in GM12878 and Pol2 ChIP-seq in
GM12891) of six conditions, more than 50% of the peaks show sta-
tistically significant differential binding between replicates. For the
other three conditions (RAD21 ChIP-seq in K562, CMYC ChIP-seq in
HeLa-S3 and PAX5 ChIP-seq in GM12878), less than 25% of the
peaks show statistically significant differential binding between
replicates. Thus overall (but not always), MAnorm (or similar
methods) can indeed help producing a robust peak list shared by
all replicate experiments. However, it should be noted that false
positive peaks are likely to display low number of reads in each
replicate experiment, and thus are unlikely to be called differen-
tially bound across experiments.
3.3. Data analysis and integration to determine biological validity of a
sample
The promoter proximity of binding and its preference for speci-
fic sequence motifs are characteristics of many transcription fac-
tors and can be used as a proxy to establish biological validity of
ChIP-seq samples. We annotated peaks with their distance to the
nearest transcription start sites (TSS). This revealed differences
between replicates, especially for dissimilar conditions (Fig. 1C,
peak distribution plot, and Figs. S5–61G). We also performed de
novo motif discovery on all 135 experiments. Out of the 18 condi-
tions with dissimilar peak lists, 6 (33%) showed a discrepancy
between the de novo motifs identified in the replicate experiments
(Fig. 1C, motif logos, Fig. S3 and Table S1). This was the case for one
of the 13 sensitive conditions (8%), and one of the 26 similar
conditions (4%). We then systematically investigated the replicates
for the dissimilar conditions to determine whether these or any
other evidence put higher confidence on one or few replicate(s)
over other(s). We first illustrate two cases where additional
analysis showed that one replicate appears more relevant than
the other.
1. HDAC2 experiments in K562 cell line – histone deacetylase
HDAC2 experiments in K562 cell line were generated by the
Broad and HudsonAlpha laboratories using different antibodies.
When comparing to other ENCODE ChIP-seq experiments, Hud-
sonAlpha HDAC2 ChIP-seq clusters with P300 (as identified by
the Sydh laboratory) while Broad HDAC2 clusters with HDAC6
(Fig. S4A). In H1-hESC cell line, HDAC2 (HudsonAlpha antibody)
and P300 cluster together as well. The discrepancy between the
two HDAC2 experiments is likely to be due to different antibody
specificities. Wang et al. [15] identified that a cell-line specific
secondary motif that mediates the binding of HDAC2 in K562
was a GATA motif. Accordingly, the GATA motif is the top motif
enriched in the HudsonAlpha sample (P value < 1e1216),
whereas the REST-NRSF motif is the top enriched motif in the
Broad sample (P value < 1e275). As GATA1 is a master regula-
tor of erythropoiesis and K562 is a leukaemia derived cell line,
the HudsonAlpha HDAC2 experiment (and antibody) appears
more reliable than the Broad HDAC2 in K562.2. CMYC experiments in H1-hESC cell line – CMYC replicate exper-
iments in H1-hESC cell line were generated by the Stanford and
UTA laboratories. Amongst H1-hESC samples, the Stanford
CMYC replicate clusters together with MAX and is part of a lar-
ger cluster including RNA polymerase II and other promoter
associated factors, such as TAF1 and TBP. This is in accordance
with the proven role of CMYC in RNA polymerase II elongation
[16]. The UTA CMYC sample in contrast does not cluster with
any of the above samples, putting the biological integrity of this
sample in doubt. Corroborating this, the CMYC motif is enriched
in the Stanford, but not the UTA sample (Figs. S3G and H).
Although further analysis is indeed a way forward as demon-
strated above, it does not always provide sufficient evidence to pre-
fer one experiment over other for the same condition. For instance,
the two CHD1 ChIP-seq experiments in H1-hESC are dissimilar
(Fig. S9A). Interestingly, the ‘‘common”peaksdidnot select forpeaks
of higher coverage for one of the replicates (Fig. S9C). De novomotif
discovery detected different primary (Figs. S3D and E) and sec-
ondarymotifs in each experiment, but neither appearsmore biolog-
ically relevant than the other. When peak overlap of all CHD1
experiments in the ENCODE resource is clustered, neither of the
two experiments appear closer than the other to the CHD1 ChIP-
seq experiments done in GM12878 and in K562. Taken together,
we can only conclude that both experiments are dissimilar, cannot
be intersected ormerged, and that our current knowledge is insuffi-
cient to select the most biologically relevant experiment.
4. Discussion
The ENCODE ChIP-seq data is of great value to computational
and non-computational biologists alike and is widely used by the
scientific community [1,2]. One great strength of this consortium
is that its transparency and extensive data release policy. Taking
advantage of this, we noted that the data contains several different
replicate experiments for the same factor in the same cell line
under the same treatment (or absence of treatment), without indi-
cation about the consistency between replicates or recommenda-
tions about which peak list to use. We performed an
independent assessment of the consistency between these repli-
cate experiments by categorizing the conditions with replicates
in three groups: similar, sensitive and dissimilar. We found 18 of
57 showed a very low overlap between peak lists from replicate
experiments. Assuming that a discordance is due to only one faulty
sample amongst the replicate experiments, a simple extrapolation
of these results to all 690 ENCODE ChIP-seq samples puts the bio-
logical validity of about 14% of them into question. To examine
this, we compared the clustering of binding sites of multiple fac-
tors studied by ChIP-seq across cell types. Thirty-eight factors have
been studied by ENCODE in both H1-hESC and K562 cell lines.
NRSF in K562 clusters together with P300 while it does not cluster
together with P300 in H1-hESC. SP1 and SP2 cluster together in
K562 while SP1 shows highest peak overlap with P300 in H1-
hESC cells. Due to the absence of replicates, it is impossible to
know from this data alone whether these factors have a context-
specific (cell type specific) binding profile, or if the observed differ-
ences are emerging from variable quality between experiments.
The practical question still remains which replicate to use or
what is the best way to merge replicates. Intersecting peak lists
is the most conservative approach, and retains a small number of
high quality peaks. Although the most reasonable approach in
most situations, it suffers a drawback: replicating a ChIP-seq
experiment will effectively reduce the number of peaks detected.
We therefore suggest other strategies, on a case-by-case basis
(Table S1). For most conditions in the similar or sensitive category,
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similar category, we used additional analyses or information to
suggest one peak list likely to be more reliable than the other(s).
For example, for the CMYC ChIP-seq in H1-hESC, we recommend
using replicate 1 based on de novo motif discovery (Figs. S1E and
F). For RNA pol2 phosphoS2 ChIP-seq in K562, we suggest replicate
2 with a higher proportion of peaks downstream of a TSS. In other
cases, we prioritized replicate(s) based on the peak overlap with
ChIP-seq of the same factor in other cell line(s) or under a different
treatment (Fig. S3).
Taken together, this study demonstrates that the high standards
set for technical quality control achieved by the ENCODE consor-
tium does not guarantee the robustness of the sample. This high-
lights a potential caveat concerning mining of the vast amounts
of data deposited in the public domain in general, where even high
technical quality of the data is not always documented.
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